ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

US News

Fate secure FDA seal of approval

29 Jul 2014 @ 20:52
Phase 1b PROVIDE Study in Pediatric Patients with Inherited Metabolic Disorders Expected to Begin in 4Q14 Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug Application […]
 

MACOM report $112m revenue for Q3

29 Jul 2014 @ 20:43
M/A-COM Technology Solutions Holdings, Inc. (Nasdaq:MTSI), a leading supplier of high performance analog semiconductor solutions, today reported its financial results for its fiscal third quarter ended July 4, 2014. Third Quarter Fiscal Year 2014 GAAP Results: – Revenue was $112.4 million, compared to $107.8 million in the prior fiscal quarter and $83.5 million in the […]
 

Fitbug holdings secure loan and set court date

29 Jul 2014 @ 20:33
Secures £1,750,000 Loan on Attractive Terms – February 2015 Trial Date Set for Legal action Against Fitbit Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, has announced that NW1 Investments Limited and Kifin Limited , a Kirsh Group subsidiary have together agreed to loan £1,750,000 to the Company. The […]
 

Reckitt Benckiser Is the FTSE Beacon Today

28 Jul 2014 @ 17:34
Whether you look at its share price or its operational reports, Reckitt Benckiser LSE:RB.) simply continues to impress. It’s share price finished up today by 2.66%, a gain of 135.00 pence from Friday’s close of 5,070. Shares closed today at 5,205 after opening at 5,170 and reaching an intra-day high of 5,250, just shy of […]
 

Theravectys files suit against IMDZ

27 Jul 2014 @ 17:53
IMDZ argue that repeats some claims made by TVS in prior lawsuit that it previously voluntarily dismissed. Immune Design (Nasdaq:IMDZ) announced today that the day after it began trading on the Nasdaq Global Market, Theravectys SA filed a lawsuit against the company repeating claims that it had made in a prior lawsuit which TVS had […]
 

Carillon & Balfour Surge on Merger Talk

25 Jul 2014 @ 15:59
At 16 minutes past 9:00 am GMT yesterday, 24 July 2014, Carillon (LSE:CLLN) announced that it had won a contract with the Ministry of Defense worth £2.8 billion. Carillon’s share price barely budged, despite analysts describing the deal as a game changer for the company. The contract for maintaining and upgrading military facilities was won as […]
 

Hancock release Q2 data

24 Jul 2014 @ 22:35
Hancock Holding Company (Nasdaq:HBHC) today announced its financial results for the second quarter of 2014. Operating income for the second quarter of 2014 was $49.6 million or $.59 per diluted common share, compared to $49.1 million, or $.58 in the first quarter of 2014. Operating income was $46.9 million, or $.55, in the second quarter […]
 

MacroGenics secure FDA clearing for DART

24 Jul 2014 @ 22:31
Triggers $5M milestone payment from Servier MacroGenics, Inc. (Nasdaq:MGNX), a clinical stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that its investigational new drug (IND) for MGD007 has been cleared by the U.S. Food and Drug Administration (FDA) to...
 

Meridian Interstate announces offering results

24 Jul 2014 @ 22:28
Meridian Interstate Bancorp (Nasdaq:EBSB), the holding company for East Boston Savings Bank, announced today the results of the stock offering of Meridian Bancorp, Inc., a newly formed corporation that is the proposed successor holding company for East Boston Savings Bank. The closing of the offering and the conversion from the mutual holding company to stock […]
 

61% Increase in Revenue Drives Facebook Past IBM in Valuation

24 Jul 2014 @ 17:08
Just one look at the chart and you will see why all the ballyhoo about the botched Facebook (NASDAQ:FB) IPO was really “Much Ado About Nothing.” As of this very moment, Facebook’s share price of $76.37 is almost exactly double its IPO share price of $38.23 on 28 May 2012 and more than quadruple it […]
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com